Page 50 - Danielle Peyton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NEW YORK, April 28, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against bluebird bio, Inc. (“bluebird” or the “Company”) (NASDAQ: BLUE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone […]

 NEW YORK, April 28, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Hertz Global Holdings, Inc. .   Such investors are advised to contact Danielle Peyton at...

NEW YORK, April 28, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Reviva Pharmaceuticals Holdings, Inc. . Such investors are advised to contact Danielle...

NEW YORK, April 28, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PowerFleet, Inc. .  Such investors are advised to contact Danielle Peyton at...

NEW YORK, April 28, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company . Such investors are advised to contact Danielle Peyton at...